Montana Medical Research

Executive Summary

Montana Medical Research (MMR) is a privately held clinical research center founded in 1998 and headquartered in Missoula, Montana. The company specializes in the management and execution of Phase II through Phase IV clinical trials, with a focused therapeutic expertise in cardiovascular and metabolic diseases. By serving as a reliable execution partner for pharmaceutical sponsors and contract research organizations (CROs), MMR facilitates patient access to novel treatments while generating revenue through trial service fees. With over two decades of operational experience, the company has built a strong reputation in the Mountain West region, though it remains a small, regional player in the highly competitive clinical trial services market. MMR's business model positions it to benefit from the steady demand for clinical trial infrastructure, particularly as pharmaceutical companies continue to outsource trial management to specialized sites. The company's long track record and niche focus on high-prevalence disease areas provide a stable foundation, but growth is constrained by its limited geographic footprint and lack of proprietary drug assets. To expand, MMR would likely need to secure new trial contracts from major sponsors, invest in patient recruitment capabilities, or pursue strategic partnerships. Given its established presence but modest scale, the company offers conservative, non-dilutionary exposure to the clinical research sector.

Upcoming Catalysts (preview)

• Q3 2026Award of a Large Phase III Cardiovascular Trial Contract60% success
• Q4 2026Expansion into a New Therapeutic Area or Geographic Site40% success
• Q1 2027Publication of Positive Trial Results from a Lead Study50% success